Astrazeneca plc Profit Margin

Astrazeneca plc (AZN) currently reports a profit margin of 17.53% as of December 2025. That compares with 13.02% in the prior-year period — up 34.6% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Astrazeneca plc's profit margin history and peer comparisons.

Astrazeneca plc's profit margin increased from 13.02% to 17.53% — a 34.6% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Astrazeneca plc's profit margin of 17.53% is higher than the Healthcare sector average of 13.89%. That is roughly 26.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Astrazeneca plc's current 17.53% should be judged against Healthcare norms (sector average: 13.89%) and against AZN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 17.53%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Astrazeneca plc, and consider following AZN for alerts when major investors trade the stock.